The Ben-David lab applies genomic and functional approaches to studying a fundamental trait of cancer, called aneuploidy  a change in the number of chromosomes in cancer cells. Ultimately, his research aspires to expand the understanding of the genetic basis of cancer, and to open new avenues for personalized cancer treatments.